AstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India Limited has received shareholder approval via postal ballot to shift its registered office from the State of Karnataka to the State of Maharashtra, along with consequential amendments to its Memorandum of Association. The special resolution was passed with overwhelming majority — 21,270,139 votes in favor (99.99%) versus 2,582 votes against (0.01%) out of 274 participating members. The voting was conducted entirely through remote e-voting per MCA COVID-era circulars, open from April 12, 2026. The Scrutinizer's Report confirms the resolution achieved the requisite majority.
The relocation is an administrative change with potential regulatory/tax implications given Maharashtra's business environment. It does not alter shareholding structure or trigger any mandatory offers, and is unlikely to have a direct stock price impact.